A. EROL Et Al. , "Ribosome biogenesis mediates antitumor activity of flavopiridol in CD44<sup>+</sup>/CD24<sup>-</sup> breast cancer stem cells.," Oncology letters , vol.14, pp.6433-6440, 2017
EROL, A. Et Al. 2017. Ribosome biogenesis mediates antitumor activity of flavopiridol in CD44<sup>+</sup>/CD24<sup>-</sup> breast cancer stem cells.. Oncology letters , vol.14 , 6433-6440.
EROL, A., Acikgoz, E., GUVEN, U., DUZAGAC, F., TURKKANI, A., COLCIMEN, N., ... OKTEM, G.(2017). Ribosome biogenesis mediates antitumor activity of flavopiridol in CD44<sup>+</sup>/CD24<sup>-</sup> breast cancer stem cells.. Oncology letters , vol.14, 6433-6440.
EROL, Abdullah Et Al. "Ribosome biogenesis mediates antitumor activity of flavopiridol in CD44<sup>+</sup>/CD24<sup>-</sup> breast cancer stem cells.," Oncology letters , vol.14, 6433-6440, 2017
EROL, Abdullah Et Al. "Ribosome biogenesis mediates antitumor activity of flavopiridol in CD44<sup>+</sup>/CD24<sup>-</sup> breast cancer stem cells.." Oncology letters , vol.14, pp.6433-6440, 2017
EROL, A. Et Al. (2017) . "Ribosome biogenesis mediates antitumor activity of flavopiridol in CD44<sup>+</sup>/CD24<sup>-</sup> breast cancer stem cells.." Oncology letters , vol.14, pp.6433-6440.
@article{article, author={Abdullah EROL Et Al. }, title={Ribosome biogenesis mediates antitumor activity of flavopiridol in CD44<sup>+</sup>/CD24<sup>-</sup> breast cancer stem cells.}, journal={Oncology letters}, year=2017, pages={6433-6440} }